Pharmaceutical

Wane in Covid demand hurts Walgreens as profits drop to $118m

Walgreens Boots Alliance readjusted its 2023 outlook amidst mixed fiscal Q3 results.

Jun 27, 2023 - 20:00
Wane in Covid demand hurts Walgreens as profits drop to $118m
Walgreens Boots Alliance readjusted its 2023 outlook amidst mixed fiscal Q3 results.
Read the original article

Tags:

Previous Article

Rystiggo receives FDA approval, strengthening UCB’s myasthenia gravis portfolio

Next Article

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Which drugs are most likely to be approved in Stem Cell...

Mar 28, 2024

STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access

STAT+: Pharmalittle: U.S. to impose inflation penalties...

Dec 15, 2023

STAT+: ViiV Healthcare and Doctors Without Borders tussle over contract terms for an HIV drug

STAT+: ViiV Healthcare and Doctors Without Borders tuss...

Aug 17, 2023